Navigation Links
New Zealand to Ban "party Pills"

The New Zealand cabinet Thursday agreed to ban popular "party pills" and hopes to pass a law by the end of the year, Associate Health Minister Jim Anderton said.

The benzylpiperazine (BZP) and related pills are popular with night clubbers and partygoers and are widely sold in specialist "party pill" stores, liquor outlets and some corner grocery shops.

Anderton said he hoped Parliament would pass legislation to make the party pills an illegal class C1 drug, which would put it on the same level as cannabis.

"The research, analysis of submissions, advice from experts and agencies ... all added up in my view to a ban and I took that recommendation to my cabinet colleagues," Anderton said.

Party pills have similar effects to amphetamines but are less potent.

Anderton said studies in New Zealand confirmed that the ill effects of party pills could include insomnia, headaches, nausea and anxiety. Some people had reported seizures.

Under the proposed law, possession of the drug could lead to a fine of up to 500 dollars (380 US) and three months in prison. Those supplying the drug could be jailed for up to eight years.

Anderton said there would be a six-month amnesty for those found in possession of the drug after the law was passed, although suppliers would be prosecuted immediately.

New Zealand's Massey University found one in five people between the ages of 13 and 45 had tried party pills at least once, and about 15 percent had used them in the past 12 months.

BZP and related drugs are currently banned in the US, Australia, Japan, Denmark, Belgium, Greece and Malta.


'"/>




Page: 1

Related medicine news :

1. A Cheap Device to Stop Snoring from New Zealand
2. New Zealand Researchers Call For Tobacco-Free Society
3. Bird flu may cause a blackout in New Zealand
4. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
5. New Zealand Prepares Itself For Pandemic
6. Productivity in New Zealand hit by Absenteeism through Health Reasons
7. Heart Disease Increasing At An Alarming Rate In New Zealand
8. Diabetes, The Silent Killer of New Zealand
9. Doctors In New Zealand Warns Against Using Ayurveda Medicines
10. New Zealand To Issue Graphic Warnings In Cigarette Packs
11. Indian Students in New Zealand Feel Insecure
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Zealand Ban party Pills

(Date:12/14/2009)... Dec. 14 Heska Corporation (Nasdaq: ... a leading provider of veterinary diagnostic and ... installation of the Company,s new DRI-CHEM® 7000 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) ,, Customers receiving ... multi-patient clinical chemistry analyzer available to the ...
(Date:12/14/2009)... Enough To Wear Pink(TM) (TETWP), the grassroots cowboy ... anniversary at the signature Tough Enough To Wear ... (Wrangler NFR) in Las Vegas. While pink is ... support of the western industry and rodeo fans ... shirts, hats, bracelets and more. ,, Through ...
(Date:12/14/2009)... common CT procedures vary widely and are higher than generally thought, ... study led by University of California, San Francisco (UCSF) ... ... 14, 2009 -- Radiation doses from common CT procedures vary widely ... for cancer, according to a new study led by University of ...
(Date:12/14/2009)... The Hemophilia Federation of America (HFA) ... involving the Teamsters Local 929 and the American ... blood system depends on skilled workers to provide ... distilled into products such as clotting factor for ... ,, The Division of Blood Services at ...
(Date:12/14/2009)... small and shouldn,t worry most users, researcher says , , ... take antidepressants may have a small but statistically significant ... not on the medications, a new study finds. , ... stressed Dr. Jordan W. Smoller, an associate professor of ... a report in the Dec. 14 issue of ...
Breaking Medicine News(10 mins):Health News:Heska Announces Installation of New Chemistry Analyzer 2Health News:Heska Announces Installation of New Chemistry Analyzer 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 2Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 3Health News:Tough Enough To Wear Pink(TM) Celebrates Fifth Anniversary 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5Health News:HFA Voices Blood Safety Concerns 2Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3
... women,s wombs over several assisted reproduction cycles that use ... cheaper than transferring two or more embryos at one ... series of patients who choose to have only one ... (eSET). , The authors of the Finnish study published ...
... Capture, Streamlines Health Records Documentation , ... ... Corporation , a leading developer of healthcare software solutions for ... national leader in enterprise content management and business process automation, ...
... Changes that Hold Health Care Providers Responsible when ... their products are implicated in harm to patients, ... wide contractual and legal protection that renders them ... University of Pennsylvania School of Medicine, ...
... Dealing with a difficult economy and a new ... the Managed Care Executive Group,s (MCEG) annual meeting held in ... Top Ten issues list the group produces each year. ... of strategic positives funded by the federal stimulus package that ...
... Most cervical cancers arose from strains covered by the shot, ... majority of invasive cervical cancers in New Mexico in the ... (HPV16) and HPV type 18 (HPV18), says a new study. ... HPV18-positive cancers were an average of five years younger than ...
... from human papilloma virus type 16 (HPV16) and HPV type ... cancers in New Mexico in the 1980s and 1990s, according ... issue of the Journal of the National Cancer Institute. ... HPV16- or HPV18-positive cancer was 5 years younger than that ...
Other Medicine News:Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 2Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 3Health News:Single embryo transfer is the cheapest and most effective strategy for assisted reproduction 4Health News:iMedica and Imagetek Team up to Ease Transition to Paperless Medical Practice 2Health News:iMedica and Imagetek Team up to Ease Transition to Paperless Medical Practice 3Health News:iMedica and Imagetek Team up to Ease Transition to Paperless Medical Practice 4Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 2Health News:Why Are Healthcare Information Manufacturers Free of All Liability When Their Products Can Result in Medical Errors? 3Health News:Economy and New President Shape This Year's Top Ten Issues Facing Managed Care Executives 2Health News:Economy and New President Shape This Year's Top Ten Issues Facing Managed Care Executives 3Health News:HPV Data May Aid Vaccine's Effectiveness 2Health News:Human papillomavirus genotype distribution in New Mexico cervical cancers 2
(Date:12/14/2009)... 14 Transcept Pharmaceuticals, Inc. (Nasdaq: ... a Notice of Allowance from the United States ... U.S. patent application no. 11/060,641, which covers the ... tartrate sublingual tablet), the lead Transcept product candidate. ... earlier than February 2025. ,, "This is the ...
(Date:12/14/2009)... Dec. 14 In response to an ... 2009, in which the Agency recommended that healthcare ... (SS1) sterile processing system, hospitals throughout the U.S. ... alternatives to that product. According to the FDA, ... SS1 that may affect the safety or the ...
(Date:12/14/2009)... directors of Eli Lilly and Company (NYSE: ... quarter of 2010 of $0.49 a share on outstanding ... March 10, 2010 to shareholders of record at the ... ,, Lilly, a leading innovation-driven corporation, is developing a ... research from its own worldwide laboratories and from collaborations ...
Breaking Medicine Technology:Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 2Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 3Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R) 4ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 1New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 2New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 3New Program to Bring University of Florida Incubator Companies Millions in New Contracts 14804 4SourceMedical Earns Cardinal Health Innovation Award 61207 1SourceMedical Earns Cardinal Health Innovation Award 61207 2The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 1The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 2The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 3The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 4The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 5The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 6The Performance Management Institute of Australia Issues a Warning for Business Leaders 61202 7
... for 4Q07/1Q08, DALLAS, Aug. 20 Access ... update on the clinical,development plan of ProLindac, its ... additional human clinical trials to be initiated in,late ... recurrent ovarian,cancer patients, designed to optimize single agent ...
... 17 AutoGenomics, a leader in,developing automated molecular ... that it submitted to the FDA for 510(k) ... the Harvard Medical,School-Partners HealthCare Center for Genetics and ... a drug prescribed to help prevent,blood clots. With ...
Other Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity 2
... The Plan-Neofluar 63x/1.25 Oil Ph3 ... reflected-light reflection contrast. This method ... brightfield microscopy, such as cells ... a Petri dish. Moreover, this ...
... high-power, apochromatically corrected objectives ... the most exacting demands ... are suitable for visual ... 25 mm and feature ...
... redesigned by Nikon allowing the contrast direction ... the objective. That direction, once set, is ... 10x to 40x.,Apodized phase contrast objectives,Nikon's Apodized ... image by reducing internal reflections. The result ...
... Featuring an extra-high transmission rate, especially ... comparable to the CFI plan Achromat ... fluorescence observation and photomicrography. Because ... function as multipurpose objectives for brightfield, ...
Medicine Products: